NFL Biosciences (FRA:82F) EBITDA Margin %: 0.00% (As of Dec. 2025)


FRA:82F NFL Biosciences SA FRA:82F
28 GF Score
Price €0.78
! 1 Warning Sign
View Full Analysis

What is NFL Biosciences EBITDA Margin %?

NFL Biosciences FRA:82F -0.13% 28 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:82F with a GF Score™ of 28/100. The stock has 1 warning sign investors should review. Among 938 Biotechnology companies, NFL Biosciences ranks worse than 106609.7% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. NFL Biosciences's EBITDA for the six months ended in Dec. 2025 was €-1.69 Mil. NFL Biosciences's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, NFL Biosciences's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

NFL Biosciences  (FRA:82F) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

NFL Biosciences EBITDA Margin % Related Terms

NFL Biosciences EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for NFL Biosciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NFL Biosciences EBITDA Margin % Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

NFL Biosciences Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:82F vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, NFL Biosciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NFL Biosciences EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NFL Biosciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where NFL Biosciences's EBITDA Margin % falls into.


FRA:82F
28GF Score
NFL Biosciences SA FRA:82F
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NFL Biosciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

NFL Biosciences's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-3.757/0
= %

NFL Biosciences's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.685/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
NFL Biosciences (FRA:82F) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NFL Biosciences and its competitors. According to the industry distribution chart, NFL Biosciences ranks #999999 out of 938 companies in the Biotechnology industry.
Is NFL Biosciences' EBITDA Margin % too high?
NFL Biosciences' current EBITDA Margin % is 0.00%. Based on the distribution chart, NFL Biosciences ranks #999999 out of 938 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, NFL Biosciences has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does NFL Biosciences' EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, NFL Biosciences ranks #999999 out of 938 companies for EBITDA Margin %. This places NFL Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NFL Biosciences and its competitors. NFL Biosciences's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NFL Biosciences stock overvalued right now?
NFL Biosciences (FRA:82F) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. NFL Biosciences' overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For NFL Biosciences (FRA:82F), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NFL Biosciences Business Description

Other Exchanges ALNFL:France
Address 199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
28GF Score

Get the complete analysis for FRA:82F

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.78
Price